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Necrotizing angiitis or vasculitis are terms 
applied to clinical disorders in which there is 
segmental inflammation of the blood vessels. Clin-
ical syndromes are defined on the basis of the 
dimension of the involved blood vessels, the char-
acter of the vascular lesions, the frequency of 
involvement of specific organs, and the presence or 
absence of serologic abnormalities. Division with 
respect to the size of the affected blood vessels is 
into those disorders in which large blood vessels, 
especially arteries, and those in which small ves-
sels, notably arterioles and venules are involved 
(Tab. n. The caliber of the affected blood vessels 
determines the clinical symptoms and signs as well 
as the morphologic presentation in the skin. Al-
though not considered in this review, examples 
of involvement of large vessels include periarteritis 
(polyarteritis) nodosa that is appreciated in the 
skin as nodular lesions over an artery [1,2] and 
giant-cell (temporal) arteritis that is present as 
erythema overlying the affected vessel [3]. Both 
Wegener's granulomatosis [4] and granulomatous 
angiitis of Churg and Strauss [5] affect large as 
well as small vessels; the skin lesions in both 
entities are present as cutaneous nodules with 
necrosis and a variety of erythem~tous, purpuric, 
and pustular lesions. The preferential involvement 
of arterioles and venules in the absence of involve-
ment of large vessels has been designated as 
hypersensitivity angiitis [6,7]; this form of vasculi-
tis may affect a variety of organs including the skin 
in which the cutaneous venule is the site of 
vascular damage [8,9]. The skin is the most 
frequent site in which this form of necrotizing 
angiitis is recognized, and this review will consider 
cutaneous necrotizing angiitis with emphasis on 
pathobiologic mechanisms. 
CLINICAL PRESENTATIONS OF CUTANEOUS 
NECROTIZING ANGIITIS INVOLVING 
VENULES 
Palpable Purpura 
Cutaneous necrotizing angiitis may be present in 
the skin as a polymorphous panoply of lesions; 
however, the most diagnostic and consistently 
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present lesion is the erythematous papule that does 
not blanch with the application of external pres-
sure (palpable purpura) [10,11]. Cutaneous necrot-
izing angiitis most often appears over the lower 
extremities; however, the eruption may occur on 
any portion of the skin and is seen especially over 
dependent areas, such as the back and gluteal 
regions of recumbent patients. The vascular 
lesions occur in episodes at irregular intervals; 
individual lesions last from 1 to 4 weeks and 'resolve 
leaving hyperpigmentation, atrophic scars, or 
rarely, no residua. An episode of vascular lesions 
may be attended by fever, malaise, arthralgias, or 
myalgias as well as by additional symptoms relat-
ing to specific organ involvement. Symptoms usu-
ally referred to the lesional site include pruritus or 
burning; less frequently, pain, or rarely no symp-
toms are present. 
Palpable purpura has been associated with a 
variety of collagen-vascular diseases, notably 
rheumatoid arthritis and less commonly Sjogren's 
syndrome and systemic lupus erythematosus. 
Other reported associations include cryo-
globulinemia [11-13], lymphoproliferative disor-
ders [14], streptococcal infections [15], hepatitis-
associated antigen [16], C2 deficiency [17 J,.. and a 
variety of medications. In many patients with 
palpable purpura, however, it is rather difficult to 
ascertain whether the eruption is associated with 
concomitant disease processes or is the result of 
administered medications. Nevertheless, a large 
group of patients exists with cutaneous necrotizing 
angiitis of unknown cause; in these individuals the 
vascular lesions may involve a variety of organ 
systems or remain restricted to the skin. The most 
widely recognized idiopathic disorder is the 
Henoch-Schonlein syndrome in which the skin, 
joints, gastrointestinal tract, and kidneys are char-
acteristicallyaffected [18]. Less common idiopath-
ic entities are nodular vasculitis [19] and erythema 
elevatum diutinum [20], both of which are mor-
phologic variants of cutaneous necrotizing angiitis. 
Recurrent Urticaria 
It has recently been shown that episodes of 
recurrent or chronic urticaria without or with foci 
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of purpura may be a manifestation of underly-
ing cutaneous necrotizing angiitis [21-24]. In our 
study of patients with urticaria without purpuric 
foci [22], the lesions appeared as circumscribed, 
raised, indurated, and erythematous wheals that 
blanched with the application of external pressure. 
The urticaria occurred in episodes with a frequency 
ranging from once daily to once monthly; any 
portion of the skin including mucous membranes 
could be affected. An individual lesion usually 
lasted fewer than 24 hr and in no case longer than 
72 hr. There were no residua except the rare 
instance of hyperpigmentation. Symptoms 
referred to the lesions include pruritus or burning; 
occasionally there were no symptoms. Our group of 
patients with the urticarial form of cutaneous 
necrotizing angiitis now includes 12 individuals 
(Tab. II). This syndrome affects women primarily 
and is associated with arthralgias that for the most 
part tend to be episodic and accompany the skin 
lesions; occasionally arthritis, abdominal pain, 
and adenopathy are noted. The most consistently 
abnormal laboratory study is an elevated erythro-
cyte sedimentation rate that is not seen in the more 
usual forms of recurrent urticaria without vasculi-
TABLE 1. Necrotizing angiitis 
Large Vessels 
Periarteritis (polyarteritis) nodosa 
Wegener's granulomatosis 
Giant-cell (temporal) arteritis 
Polymyalgia rheumatica 
Granulomatous angiitis of Churg and Strauss 
Small Vessels 
Associated with collagen-vascular diseases 
Rheumatoid arthritis 
Systemic lupus erythematosus 
Sjogren's syndrome 
Hypergammaglobulinemic purpura 
Cryoglobulinemia 
Lymphoproliferative disorders 
Drug-induced reactions 
Hepatitis-associated antigenemia 
Bacterial infection 
C2 Deficiency 
Idiopathic 
Henoch-Schonlein syndrome 
Nodular vasculitis 
Erythema 'elevatum diutinum 
Degos' disease (malignant atrophic papulosis) 
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tis; the antinuclear factor and serum IgE levels are 
negative and normal, respectively. 
There may be renal involvement in the form of 
glomerulonephritis [21,23 ]. In one of our patients 
(SK) [25], an abnormal urine sediment containing 
erythrocytes and red blood cell casts was noted 
with proteinuria and the maintenance of a normal 
creatinine clearance. Examination of a renal bi-
opsy specimen showed diffuse glomerulonephritis 
accompanied by inflammation of the arcuate vein; 
immunofluorescence studies showed the deposition 
of IgG, IgM, C1q, C4, and C3; and ultrastructural 
studies showed the deposition of electron-dense 
deposits in subepithelial, subendothelial, and mes-
angial locations. The true incidence of glomerulo-
nephritis occurring in patients with recurrent urti-
caria as a manifestation of vasculitis is unknown. 
ANALYSIS OF THE COMPLEMENT SYSTEM IN 
PATIENTS WITH CUTANEOUS NECROTIZING ANGIITIS 
Patients with either palpable purpura or recur-
rent urticaria as manifestations of cutaneous 
necrotizing angiitis can be divided into two popu-
lations with respect to the complement sys-
tem-one group with hypocomplementemia and an-
other with a normal complement system. In 
patients with palpable purpura and concomitant 
collagen-vascular diseases or cryoglobulinemia, 
the complement abnormality reflects the associ-
ated disease or the existence of a cryoglobulin [11]. 
For example, in patients with rheumatoid arthritis 
and vasculitis in whom the level of rheumatoid 
factor was high, hypocomplementemia was present 
with low levels of el, C4, and C2. This serum 
profile is consistent with activation of the classic 
pathway and is similar to the utilization profile 
observed in the synovial fluid of patients with 
rheumatoid arthritis [26]. In patients with sys-
temic lupus erythematosus and vasculitis, there 
was activation of the classic pathway with pro-
found depletion of C1q, recruitment of the ampli-
fication mechanism [27], and utilization of the 
terminal complement sequence. These changes are 
identical to complement abnormalities in patients 
with systemic lupus erythematosus and active 
renal disease without vasculitis. The amplifying or 
positive feedback loop operates so that the C3-
cleaving enzyme formed is capable of generating 
additional C3b from C3 to interact with properdin 
and factors Band D of the alternative pathway to 
form more convertase. 
In patients with Sjogren's syndrome, the com-
TABLE II . Clinical and laboratory features in patients with uasculitis manifested as urticaria 
Patient CH RS EL ND FD MT WC AS RW SK BV CT 
Age/sex 25/F 29/F 68/F 29/F 54/F 38/F 33/F 46/F 48/M 31/F 30/F 301M 
Duration of 10 yr 3 yr 5 yr 25 yr 3.5 yr 3mo 28 yr 2 yr 2 yr 4mo 3 yr 5 yr 
skin lesions 
Arthralgias + + + + + + + + + + + 
ESR 66 4 44 40 42 36 20 60 28 48 92 36 
CHsoa 234 194 210 211 171 214 182 ~ [§§J' []1J 1< 20/ 1< 20/ 
a Normal value 200 ± 50 (2 SD); numbers within boxes are low values. 
, 
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plement-component profile in serum reflected the 
type and nature of the underlying cryoglobulin. In 
2 patients with an IgG-IgM cryoglobulin, there 
were low levels of C4 and C2 consistent with 
activation of the classic pathway. The isolated 
cryoproteins contained bound and active Cl mole-
cules [11]. Moreover, the administration of iso-
lated, purified, radiolabeled C4 to these 2 patients 
[28] showed both hypercatabolism and hyposyn-
thesis of this molecule. These data were inter-
preted to indicate that the cryoglobulin bound and 
activated C1 with subsequent consumption of C4 
and C2. In a patient with an IgG-IgA cryoglobulin 
there were low levels of C3 and C9, and the levels of 
properdin and factor B fluctuated at the lower 
limit of normal. The levels of C1, C4, and C2 
remained in the normal range consistent with 
activation of the alternative complement pathway . 
In 1 patient with Sjogren's syndrome and vasculitis 
without a cryoprotein, the complement system was 
normal. Thus, the complement profile in serum 
was characteristic of the presence and type of 
cryoglobulins rather than presenting a uniform 
profile for cutaneous manifestations that were 
clinically indistinguishable. 
In addition to these individuals with concomi-
tant collagen-vascular diseases there are other 
patients with cutaneous necrotizing angiitis and 
hypocomplementemia. In this category are prima-
rily those individuals with vasculitis of unknown 
cause. Finally, there are patients with either pal-
pable purpura or urticaria and a normal comple-
ment system; this group probably contains the 
majority of patients, most notably those individu-
als with drug-induced vasculitis. 
TISSUE STUDIES IN PATIENTS WITH CUTANEOUS 
NECROTIZING ANGIITIS 
The traditional histopathologic criteria for the 
diagnosis of necrotizing angiitis of cutaneous ven-
ules are fibrinoid necrosis of the blood vessel wall 
and an infiltrate rich in neutrophils with the 
presence of nuclear debris and the extravasation of 
erythrocytes [29-31]. More recent studies utilizing 
the 1-JLm-thick section [32,33] technique have 
shown two distinct cellular patterns in the skin of 
patients with cutaneous necrotizing angiitis [34]. 
In individuals with hypocompleIY\entemia and 
cutaneous necrotizing · angiitis the cellular infil-
trate contains a preponderance of neutrophils over 
lymphocytes in and about the venules, whereas 
lymphocytes and activated lymphocytes are prom-
inent in these locations in the normocomplemen-
temic group. In the patients with hypocomplemen-
temia, the neutrophil:lymphocyte ratio was 4:1; in 
contrast, this ratio was 1:2 in the group with a 
normal complement system. NeitJ:Ier eosinophils, 
basophils, plasma cells, nor infiltrating macro-
phages were prominent or consistently present in 
either group. Tissue histiocytes laden with debris 
were variably · present in both patterns as were 
mast cells in various stages of hypogranulation. 
Fibrin was deposited in perivenular and intervas-
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cular locations in both patterns; the venular altera-
tions consisting of endothelial cell swelling, activa-
tion of nuclei, necrosis, and basement membrane 
thickening were comparable in both groups. The 
arterioles were never affected by'the inflammatory 
process. The recognition of two distinct cellular 
patterns in the tissue of patients with cutaneous 
necrotizing angiitis suggests that more than one 
mechanism of vascular damage may be operative. 
A CONSIDERATION OF PATHOBIOLOGIC MECHANISMS 
Cutaneous necrotizing angiitis has been attrib-
uted to a variety of mechanisms that include 
immune complexes and cellular-type hypersensi-
tivity reactions as well as mast cell involvement. 
Participation of the Mast Cell 
Hypogranulation of mast cells was noted not only 
in skin biopsy specimens of patients with cuta-
neous necrotizing angiitis [34] but also during the 
study of the evolution of cutaneous necrotizing 
angiitis in a unique patient [35]. The latter study 
was performed in a patient with spontaneous 
urticaria, arthritis , and hypocomplementemia 
involving the classic pathway; in this individual, 
cold in the form of application of ice or trauma 
induced by stroking (dermographism) elicited an 
urticarial lesion. All skin lesions, spontaneous or 
induced, showed necrotizing angiitis by routine his-
tologic assessment. The evolution of the cellular 
infiltrate and nature of the venular changes were 
further examined by the 1-JLm-thick section tech-
nique. The initial observation at 5 min after 
exposure to ice or trauma showed hypogranulation 
of the mast cells with extrusion of the granules that 
was accompanied by enlargement of the endotheli-
al cells. At 30 min, a perivenular infiltrate of 
neutrophils was present accompanied by the depo-
sition of fibrin and venular changes that included 
endothelial cell swelling with activation of the 
nuclei and necrosis. At 1 hr eosinophils appeared in 
the infiltrate as well as increased amounts of 
neutrophils and fibrin. By 24 hr, at a time when the 
skin appeared clinically normal, the cellular infil-
trate of neutrophils and eosinophils as well as the 
necrotic venular damage and fibrin were still 
present. The initial observation of mast cell de-
granulation in this study permits a consideration of 
a possible primary role for the mast cell in the 
development of cutaneous necrotizing angiitis. 
The mast cell, through its content of histamine, 
could alter the venular permeability that has been 
shoWn by ultrastructural studies as interendothe-
lial cell gaps in experimental models [36]. Similar 
alterations were observed in the skin of certain 
patients with cutaneous necrotizing angiitis [37]. 
The presence in the mast cell granule of eosinophil 
chemotactic factor of anaphylaxis (ECF -A) [38,39] 
that has been released in more ordinary forms of 
cold urticaria without vasculitis [40] and the 
release of a neutrophil chemotactic factor (NCF) 
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[41,42] could allow the accumulations of eosino-
phils and neutrophils, respectively. The generation 
and release of slow-reacting substance of anaphy-
laxis (SRS-A) would further augment vascular 
permeability [43] and of platelet activating fac-
tor(s) (PAF) would allow the recruitment of plate-
lets with their content of serotonin [44]. In addition 
to a primary role, the mast cell with its mediators 
might facilitate the localization of immune com-
plexes [45]. 
In those patients with hypocomplementemia, 
the generation of the anaphylatoxins C3a and C5a 
from C3 and C5, respectively, might augment the 
participation of the mast cell by further mast cell 
degranulation and alterations in vascular permea-
bility [46-48]. Moreover, the mast cell contains 
heparin [49] that perhaps binds and holds tissue 
fluids [50], thus contributing to the edema; its 
content of acid and neutral hydrolases could facili-
tate tissue damage [51,52]. 
Immune Complexes 
In patients with cutaneous necrotizing angiitis, 
evidence for the presence of circulating immune 
complexes is derived from their demonstration 
directly in the case of cryoproteins [11,53], from a 
variety of indirect assays [54,55], and from the 
presence in serum of hypocomplementemia 
[11,53]. In lesional tissue, immune complexes are 
inferred from the ultrastructural observation of 
electron-dense deposits [9,25] and from the dem-
onstration of immune reactants by immunofluores-
cence techniques [56-58]. Moreover, the local 
injections of histamine into the skin of patients 
with this disorder has allowed the detection of 
electron-dense material interpreted as immune 
complexes as well as neutrophils [9]. That the time 
of examination of skin tissue specimens is critical 
was shown in guinea -pig skin, in which the 
immune complexes could no longer be detected by 
immunofluorescence techniques by 18 hr [59]. The 
infiltrate comprised mainly of neutrophils with 
venular necrosis observed in the 1-,l.Lm-thick sec-
tions from the lesional skin of patients with hypo-
complementemic cutaneous necrotizing angiitis is 
also consistent with damage induced by immune 
complexes. It is of note that, in contrast to the 
Arthus reaction in experimental animals [60], in 
human lesional skin mature plasma cells were not 
noted. It seems unlikely that random biopsy speci-
mens of various ages would have failed to uncover 
such a stage. Further confirmation that immune 
complexes are operative in certain patients is the 
early detection of immunoglobulins and comple-
ment [58] as well as electron-dense deposits [9] in 
the adjacent clinically normal skin of some 
patients with cutaneous necrotizing angiitis. These 
localized immune complexes would elaborate ana-
phylatoxins to recruit neutrophils that in turn 
ingest complexes in an augmented fashion second-
ary to immune adherence and release lysosomal 
enzymes, leading to further tissue damage. More-
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over, complement-derived leukotactic activity at-
tributed to C5 was extracted from experimental 
vascular skin lesions in rats [61]. The persistent 
presence of fibrin in the lesions may be influenced 
by diminis~d tissue fibrinolytic activity in lesion-
al sites [62]. As previously discussed, the presence 
of hypogranulation of mast cells suggested a modu-
latory role for this cell in hypocomplementemic 
cutaneous necrotizing angiitis. Furthermore, circu-
lating immune complexes might participate in the 
generation of anaphylatoxins that could stimulate 
sensitized basophils to release chemical mediators 
[42], as already described for mast cells. 
Cellular Hypersensitivity Reactions 
In patients with normocomplementemic cutane-
ous necrotizing angiitis, the lesional changes show 
some characteristics reminiscent of those findings 
observed in experimentally induced contact sensi-
tivity and the tuberculin reaction [32,33]. These 
cutaneous reactions are characterized by a perive-
nular infiltrate rich in lymphocytes and activated 
lymphocytes. Neutrophils are present, infiltrating 
macrophages can replace the infiltrating monocytes 
changes include endothelial cell swelling and acti-
vation with rare necrosis. In the skin of patients 
with normocomplementemic forms of cutaneous 
necrotizing angiitis, there was also a perivenular 
infiltrate rich in lymphocytes and activated lym-
phocytes with neutrophils, a paucity of infiltrating 
macrophages, and necrotic venular damage. It is 
tempting to speculate that the tissue monocyte-
macrophages can replace the infiltrating monocyte 
in these cutaneous reactions. Even though neutro-
phils were observed in lesional skin of patients with 
normocomplementemic cutaneous necrotizing 
angiitis this change does not imply a hypocom-
plementemic phase. In these vascular lesions the 
fibrin deposition was perivenular as well as inter-
vascular, perhaps as a result of the intense vascular 
insult; whereas fibrin was exclusively deposited in 
the intervascular portions of the dermis in delayed-
type hypersensitivity reactions [63]. The presence 
of mast cell hypogranulation in vasculitis [34] as 
well as in delayed-type hypersensitivity reactions 
[33] suggests a role for the mast cell. Although 
lymphocytes possess factors capable of attracting 
basophils [64], a mast cell degranulating principle 
has not yet been reported. It is of note that the 
mouse foot-pad model of delayed-type hypersensi-
tivity involves the mast cell [65]. 
SUMMARY 
Cutaneous necrotizing angiitis may be present as 
either palpable purpura or less commonly as recur-
rent urticaria, and each clinical presentation may 
be associated with hypocomplementemia or a nor-
mal complement system. A variety of mechanisms 
may be operative in the production of necrotic 
vascular skin lesions that appear as similar, recog-
nizable morphologic lesions. These mechanisms 
include immune complexes, cellular-type hyper-
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sensitivity reactions, and initiation or modulation 
by mast cells. Two cellular patterns have been 
recognized in the skin of patients with cutaneous 
necrotizing angiitis that can be correlated with the 
involvement of the complement system in serum. 
In patients with hypocomplementemia, there is an 
infiltrate of neutrophils that is consistent with 
a process involving immune complexes; in patients 
with normocomplementemia there are lympho-
cytes and activated lymphocytes consistent with 
participation in part by cellular mechanisms. In 
both the hypocomplementemic and normocom-
plementemic forms and as well as in a unique 
patient in whom the mast cell may initiate the 
venular damage, the mast cell, with its content of 
chemical mediators, has the capacity to initiate as 
well as modulate subacute and chronic vascular 
damage. 
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DISCUSSION 
Turk: My colleague, Dr. J. J. Cream, reported 5 
years ago that there was a direct relationship between the 
chronicity of cutaneous vasculitis and the presence of 
cryoglobulinemia. Have you found a similar relationship? 
What do you think causes the development of cryo-
globulins in this condition? What do you think is the 
contribution of cryoglobulins to the pathogenesis of these 
lesions? 
Soter: Cryoglobulins have been found in patients with 
episodes of cutaneous necrotizing angiitis of chronic 
rather than acute duration. They may participate in the 
production of vascular damage if skin temperatures 
become low enough to allow their formation. They could 
bind and activate C1, leading to activation of the classic 
complement system. 
Cooper: I believe that the type of skin lesions and 
associated vasculitis you describe have also been reported 
in association with fibrotic or granulomatous lung lesions 
in which eosinophils are prominent. Some have specu-
lated that these may be initiated by chronic allergic 
reactions to antigens such as those of molds. 
What is the information on initiating factors for the 
vasculitis that you describe? Are there other footprints of 
mast cell activation, such as elevated levels of histamine 
or slow-reacting substance? Is there an effective way of 
breaking the cycle of disease activity in these patients? 
Soter: Granulomatous angiitis of Churg and Strauss 
affects predominately large vessels and is characterized 
by pulmonary involvement with eosinophilia. The term 
hypersensitivity angiitis should be restricted to involve-
ment of small blood vessels, in which pulmonary involve-
ment with eosinophilia is not seen. Histamine as assessed 
by sensitive techniques has not been sought in the 
circulation of patieLts with cutaneous necrotizing angii-
tis. There is no definitive treatment inasmuch as some 
patients respond to antihistamines, some to corticoste-
roids and others to cytotoxic agents; in some patients the 
lesions are self-Hmited. 
Reed: Perhaps I can add some information to answer 
Dr. Cooper's question. In the Wisconsin series of patients 
with hypersensitivity pneumonitis from inhalation of 
thermophilic actinomycetes or pigeon antigens, vasculitis 
has not been present either in the lung lesions or in the 
skin. In some patients with allergic bronchopulmonary 
aspergillosis who have extensive peribronchial granu-
lomas, the pulmonary vessels are caught up in the 
granulomatous lesion. We have not seen any cutaneous 
vasculitis, though patients have huge amounts of IgG 
antibody and the Aspergillus organism is living in the 
bronchial lumen and presumably producing the "meta-
bolic" antigens there . 
Tan: Have you analyzed the cryoproteins of your 
patients for presence of factors of the alternative comple-
ment pathway? I am reminded of the studies of Dr. 
Charles Christianin the early 1960s in which he was able 
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to identify Clq, IgG, and IgM in cyroproteins but, in 
addition, another component which was immunogenic 
but which was not identified. Do you have any informa-
tion on this point? 
Soter: The cryoglobulins contain C1q and Cl; C4, 
C3, and Factor B were absent with Ouchterlony agar 
diffusion analysis. Properdin was not present by proper-
din transfer. 
Voorhees: First, have you tried to prevent the 
angiitis associated with mast cell degranulation in the 
patient in whom you could reproduce the angiitis experi-
mentally, by infiltrating the area with cyclic AMP-
elevating agents prior to attempting to reproduce the 
disease? Does blockade of such mast cell degranulation 
prevent the experimentally produced lesions? Second, 
do you believe that your approach to angiitis might be 
productive in a further understanding of the pigmented 
purpuric dermatoses such as Schamberg's disease or have 
you already begun such studies? 
Soter: The local injection of 0.15 M NaCI, lidocaine, 
and histamine each results in the development of vasculi-
tis . Future work using agents that have the capacity to 
inhibit the release of mast cell mediators will be fascinat -
mg. 
Bystryn: Since in .the majority of instances mast 
cell activation causes urticaria without vasculitis, I 
wonder whether you would speculate on the factors which 
cause mast cell activation to initiate, rather than accom-
pany, necrotizing vasculitis. 
Soter: The initial degranulation of the mast cell 
with the release of histamine would produce changes in 
venular permeability with the subsequent localization of 
immune complexes in this patient with serum hypocom-
plementemia. The recruitment of the complement sys-
tem could lead to the generation of anaphylatoxins that 
in turn further degranulate the mast cell. 
Braverman: We have been using a technique to 
localize immune complexes in normal forearm skin of 
pa tients with active angiitis [J Invest Dermatol 64: 105, 
1975]. Histamine is used to produce a wheal which is 
biopsied 3 to 4 hr later and examined by electron 
microscopy and immunofluorescence. One can find elec-
tron-dense deposits within the vascular wall and infiltra-
tion by neutrophils , some of which contain phagocytized 
complexes. Thus the histopathologic picture can be 
reproduced by this technique. Saline injection alone 
did not produce neutrophil infiltration. Fibrin is scarce 
in these induced lesions in contrast to spontaneously oc-
curring lesions. The mast cell is intact and degranula-
tion has not taken place. There is no necrosis of cells in 
the vessels. In spontaneously occurring lesions, necrosis 
does not exist either, and the "necrosis" seen on light 
microscopy is probably created by a smudging appear-
ance produced by the massive deposition of fibrin in and 
around the vascular wall. 
Soter: In spontaneous lesions of cutaneous nec-
rotizing angiitis studied with the 1-,um-thick section 
technique, there were endothelial cell alterations includ-
ing apparent necrosis. 
